Advanced Search

Revoke Authorisation Upon Renunciation, Commerciodel Medicinal Product For Human Use «Lisanirc».

Original Language Title: Revoca, su rinuncia, dell'autorizzazione all'immissione in commerciodel medicinale per uso umano «Lisanirc».

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
With no aRM-35/2015-138 of February 16, 2015 's revoked, pursuant to art. 38, paragraph 9, of the Legislative Decree of April 24, 2006, n. 219, out of the firm's Italian pharmaceutical biochemist Lab Lisapharma waiver S.p.a., the marketing authorisation for the medicinal product in the boxes indicated below.
Medicine: LISANIRC.
Package: A.I.C. n. 029277011 «80 mg modified-release tablets» 20 tablets.
If the distribution channel were present stocks of medicine revoked, in the course of validity, the same will be disposed of not later than 180 days after the date of publication of this determination.